Trade
Vineet Laboratories share price
High risk
You have to be logged in to add this to Watchlist.- ₹31.95(-3.39%)July 10, 2026 15:26:57 PM IST
- NSE
- BSE
- Vol : 50.37 K (NSE + BSE)Last 20 day avg : 26.97 K
Vineet Laboratories is trading -3.39% lower at Rs 31.95 as compared to its last closing price. Vineet Laboratories has been trading in the price range of 32.91 & 31.75. Vineet Laboratories has given -11.20% in this year & -2.86% in the last 5 days. The company posted a net profit of 0.85 Crores in its last quarter.Listed peers of Vineet Laboratories include Sun Pharmaceutical Industries (-0.19%), Torrent Pharmaceuticals (-0.03%), Divi's Laboratories (0.31%).The Mutual Fund holding in Vineet Laboratories was at -% in . The MF holding has - from the last quarter. The FII holding in Vineet Laboratories was at 0.36% in 31 Mar 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Key Metrics
Updated on Jul 10, 2026, 11:27 PM UTC
- BetaLow volatility0.81Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry2.73The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Vineet Laboratories News
Vineet Laboratories Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,935.25 | -0.19 | 4,64,320.36 | 37.32 | 5.38 | 0.85 | 0.47 |
| Torrent Pharmaceuticals | 4,895.20 | -0.03 | 1,65,675.81 | 68.78 | 18.17 | 0.84 | 141.16 |
| Divi's Laboratories | 6,832.30 | 0.31 | 1,81,268.32 | 68.31 | 10.7 | 0.44 | 0.03 |
| Cipla | 1,438.75 | -0.20 | 1,16,228.74 | 27.94 | 3.37 | 0.90 | 1.11 |
| Dr Reddy's Laboratories | 1,245.50 | -1.91 | 1,03,954.01 | 24.82 | 2.92 | 0.60 | 3.22 |
Vineet Laboratories Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-30 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-27 | Right issue of Equity Shares |
| 2025-11-08 | Quarterly Results |
| 2025-10-23 | Quarterly Results |
About the company Vineet Laboratories
- IndustryBiotechnology & Drugs
- ISININE505Y01010
- BSE Code543298
- NSE CodeVINEETLAB
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Vineet Laboratories Share Price FAQs
Vineet Laboratories is trading at 31.95 as on Fri Jul 10 2026 09:56:57. This is -3.39% lower as compared to its previous closing price of 33.07.
The market capitalization of Vineet Laboratories is 60.42 Cr as on Fri Jul 10 2026 09:56:57.
The 52 wk high for Vineet Laboratories is 43.56 whereas the 52 wk low is 24.41
Vineet Laboratories can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 26.80
- Dividend Yield: 0.00%
- D/E ratio: -
Vineet Laboratories reported a net profit of -20.19 Cr in 2025.
Quick Links
EQUITY QUICK LINKS
Vineet Laboratories QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.